{"id":"NCT04292899","sponsor":"Gilead Sciences","briefTitle":"Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)","officialTitle":"A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe COVID-19","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-03-06","primaryCompletion":"2020-04-09","completion":"2020-06-30","firstPosted":"2020-03-03","resultsPosted":"2020-12-31","lastUpdate":"2020-12-31"},"enrollment":4891,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["COVID-19"],"interventions":[{"type":"DRUG","name":"Remdesivir","otherNames":["GS-5734™","Veklury®"]},{"type":"DRUG","name":"Standard of Care","otherNames":[]}],"arms":[{"label":"Part A: Remdesivir (RDV), 5 Days","type":"EXPERIMENTAL"},{"label":"Part A: Remdesivir, 10 Days","type":"EXPERIMENTAL"},{"label":"Part B: Remdesivir, 10 Days (Extension)","type":"EXPERIMENTAL"},{"label":"Part B: Remdesivir 10 days (Mechanically Ventilated)","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to evaluate the efficacy of 2 remdesivir (RDV) regimens with respect to clinical status assessed by a 7-point ordinal scale on Day 14.","primaryOutcome":{"measure":"Part A: Percentage of Participants in Each Clinical Status Category as Assessed by a 7-Point Ordinal Scale on Day 14","timeFrame":"Day 14","effectByArm":[{"arm":"Part A: Remdesivir (RDV) for 5 Days","deltaMin":8,"sd":null},{"arm":"Part A: Remdesivir for 10 Days","deltaMin":10.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1563"},{"comp":"OG000 vs OG001","p":"0.0368"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":183,"countries":["United States","China","France","Germany","Hong Kong","Italy","Japan","Netherlands","Singapore","South Korea","Spain","Sweden","Switzerland","Taiwan","United Kingdom"]},"refs":{"pmids":["32459919","38920297","33624010","32706859"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":43,"n":200},"commonTop":["Constipation","Hypokalaemia","Nausea","Hypotension","Acute kidney injury"]}}